Literature DB >> 19325170

The state of synapses in fragile X syndrome.

Brad E Pfeiffer1, Kimberly M Huber.   

Abstract

Fragile X syndrome (FXS) is the most common inherited form of mental retardation and a leading genetic cause of autism. There is increasing evidence in both FXS and other forms of autism that alterations in synapse number, structure, and function are associated and contribute to these prevalent diseases. FXS is caused by loss of function of the Fmr1 gene, which encodes the RNA binding protein, fragile X mental retardation protein (FMRP). Therefore, FXS is a tractable model to understand synaptic dysfunction in cognitive disorders. FMRP is present at synapses where it associates with mRNA and polyribosomes. Accumulating evidence finds roles for FMRP in synapse development, elimination, and plasticity. Here, the authors review the synaptic changes observed in FXS and try to relate these changes to what is known about the molecular function of FMRP. Recent advances in the understanding of the molecular and synaptic function of FMRP, as well as the consequences of its loss, have led to the development of novel therapeutic strategies for FXS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325170      PMCID: PMC2762019          DOI: 10.1177/1073858409333075

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  191 in total

1.  The fragile X mental retardation protein is associated with ribosomes.

Authors:  E W Khandjian; F Corbin; S Woerly; F Rousseau
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

2.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

3.  Epilepsy and EEG findings in males with fragile X syndrome.

Authors:  S A Musumeci; R J Hagerman; R Ferri; P Bosco; B Dalla Bernardina; C A Tassinari; G B De Sarro; M Elia
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

4.  FMRP expression as a potential prognostic indicator in fragile X syndrome.

Authors:  F Tassone; R J Hagerman; D N Iklé; P N Dyer; M Lampe; R Willemsen; B A Oostra; A K Taylor
Journal:  Am J Med Genet       Date:  1999-05-28

5.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

6.  Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission.

Authors:  Emiliano M Rial Verde; Jane Lee-Osbourne; Paul F Worley; Roberto Malinow; Hollis T Cline
Journal:  Neuron       Date:  2006-11-09       Impact factor: 17.173

7.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

8.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

Review 9.  Phenotypic variation and FMRP levels in fragile X.

Authors:  Danuta Z Loesch; Richard M Huggins; Randi J Hagerman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

10.  Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.

Authors:  Mansuo L Hayashi; Se-Young Choi; B S Shankaranarayana Rao; Hae-Yoon Jung; Hey-Kyoung Lee; Dawei Zhang; Sumantra Chattarji; Alfredo Kirkwood; Susumu Tonegawa
Journal:  Neuron       Date:  2004-06-10       Impact factor: 17.173

View more
  108 in total

Review 1.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

2.  The nonsense-mediated decay pathway maintains synapse architecture and synaptic vesicle cycle efficacy.

Authors:  A Ashleigh Long; Cecon T Mahapatra; Elvin A Woodruff; Jeff Rohrbough; Hung-Tat Leung; Shikoh Shino; Lingling An; Rebecca W Doerge; Mark M Metzstein; William L Pak; Kendal Broadie
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

Review 3.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

4.  Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase.

Authors:  Shenfeng Qiu; Charles T Anderson; Pat Levitt; Gordon M G Shepherd
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 5.  Toward fulfilling the promise of molecular medicine in fragile X syndrome.

Authors:  Dilja D Krueger; Mark F Bear
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

6.  Cranial irradiation compromises neuronal architecture in the hippocampus.

Authors:  Vipan Kumar Parihar; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 7.  Homeostatic synaptic plasticity as a metaplasticity mechanism - a molecular and cellular perspective.

Authors:  Jie Li; Esther Park; Lei R Zhong; Lu Chen
Journal:  Curr Opin Neurobiol       Date:  2018-09-11       Impact factor: 6.627

Review 8.  Potassium channel modulation and auditory processing.

Authors:  Maile R Brown; Leonard K Kaczmarek
Journal:  Hear Res       Date:  2011-03-21       Impact factor: 3.208

9.  FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels.

Authors:  Pan-Yue Deng; Ziv Rotman; Jay A Blundon; Yongcheol Cho; Jianmin Cui; Valeria Cavalli; Stanislav S Zakharenko; Vitaly A Klyachko
Journal:  Neuron       Date:  2013-02-20       Impact factor: 17.173

10.  Fragile X Mental Retardation Protein is Involved in Protein Synthesis-Dependent Collapse of Growth Cones Induced by Semaphorin-3A.

Authors:  Chanxia Li; Gary J Bassell; Yukio Sasaki
Journal:  Front Neural Circuits       Date:  2009-09-15       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.